Literature DB >> 17011788

Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: relationship to cholesterol turnover.

Vladimír Bláha1, Ctirad Andrýs, Alena Smahelová, Jirí Knízek, Radomír Hyspler, Dagmar Solichová, Milan Bláha, Zdenek Zadák.   

Abstract

Metabolic abnormalities frequently associated with type 2 diabetes, feature besides endothelial dysfunction a novel factor of low cholesterol absorption and high cholesterol synthesis. We hypothesized an association between endothelial dysfunction and disturbances in cholesterol turnover, predisposing advanced atherosclerosis in patients with type 2 diabetes. We studied 75 patients: 30 with type 2 diabetes, 30 non-diabetic subjects with a history of cardiovascular disease, and 15 healthy subjects. Plasma sterols, soluble adhesion molecules sCD14, sCD40 Ligand, monocyte chemo-attractant protein-1 (MCP-1), sE- and sP-selectins were measured with and without atorvastatin therapy. The diabetic patients showed significantly higher levels of lathosterol and lower levels of sitosterol and campesterol. Non-diabetic subjects showed no significant differences in non-cholesterol based sterols. Plasma levels of hsCRP, sE- and sP-selectins and MCP-1 were significantly increased in patients with diabetes. The plasma levels of sCD40L correlate significantly with clinical parameters of BMI and glycaemia, and the plasma levels of sP-selectin correlate significantly with parameters of glycaemia and HbA(1c). The diabetic patients without statin therapy showed a significant correlation of sE-selectin with the marker of cholesterol absorption-sitosterol and sitosterol/cholesterol ratio. The diabetic patients without statin therapy showed a significant inverse correlation of sP-selectin with the marker of cholesterol synthesis-lathosterol. Both relationships disappeared with statin treatment. We conclude that endothelial dysfunction in obese patients with type 2 diabetes mellitus and cardiovascular disease associates with obesity and glycaemic control. The relation of parameters of endothelial dysfunction (such as sP-selectin and sE-selectin) with cholesterol synthesis and absorption may be influenced by reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011788     DOI: 10.1016/j.phrs.2006.08.005

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

1.  Variation of serum monocyte chemoattractant protein-1 in patients with diabetes and metabolic syndrome.

Authors:  Huiqing Li; Xiuling Deng; Zhenqiong Li; Changqing Luo; Jianshe Liu; Yumei Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

Review 2.  Lipid deposition and metaflammation in diabetic kidney disease.

Authors:  Alla Mitrofanova; Antonio M Fontanella; Sandra Merscher; Alessia Fornoni
Journal:  Curr Opin Pharmacol       Date:  2020-11-01       Impact factor: 5.547

Review 3.  Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.

Authors:  Jun Panee
Journal:  Cytokine       Date:  2012-07-04       Impact factor: 3.861

4.  Markers of cholesterol synthesis are elevated in adolescents and young adults with type 2 diabetes.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Kathryn A Williams; R Paul Wadwa; Philip R Khoury; Thomas R Kimball; Elaine M Urbina; Sarah D de Ferranti; David M Maahs; Lawrence M Dolan; Amy S Shah; Clary B Clish; Sudha B Biddinger
Journal:  Pediatr Diabetes       Date:  2020-09-15       Impact factor: 4.866

5.  Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.

Authors:  E Santini; S Madec; V Corretti; E Ferrannini; A Solini
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

6.  Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndrome.

Authors:  Long Wang; Jason Rockwood; Danielle Zak; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Metab Syndr Relat Disord       Date:  2008-06       Impact factor: 1.894

7.  Effects of Low-Dose Atorvastatin on the Peripheral Blood Mononuclear Cell Secretion of Angiogenic Factors in Type 2 Diabetes.

Authors:  Anna Wesołowska; Hanna Winiarska; Jakub Owoc; Magdalena Borowska; Joanna Domagała; Przemysław Łukasz Mikołajczak; Saule Iskakova; Grzegorz Dworacki; Marzena Dworacka
Journal:  Biomolecules       Date:  2021-12-15

8.  Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy.

Authors:  Bashair M Mussa; Ankita Srivastava; Abeer Al-Habshi; Abdul Khader Mohammed; Rabih Halwani; Salah Abusnana
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-26       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.